148 related articles for article (PubMed ID: 29497791)
21. Dose escalation in locally advanced pancreatic cancer patients receiving chemoradiotherapy.
Chung SY; Chang JS; Lee BM; Kim KH; Lee KJ; Seong J
Radiother Oncol; 2017 Jun; 123(3):438-445. PubMed ID: 28464997
[TBL] [Abstract][Full Text] [Related]
22. A retrospective comparison of neoadjuvant chemoradiotherapy regimens for locally advanced esophageal cancer.
Sanford NN; Catalano PJ; Enzinger PC; King BL; Bueno R; Martin NE; Hong TS; Wo JY; Mamon HJ
Dis Esophagus; 2017 Jul; 30(7):1-8. PubMed ID: 28475728
[TBL] [Abstract][Full Text] [Related]
23. Chemoradiotherapy Versus Chemotherapy Alone for Unresected Nonmetastatic Gallbladder Cancer: National Practice Patterns and Outcomes.
Verma V; Surkar SM; Brooks ED; Simone CB; Lin C
J Natl Compr Canc Netw; 2018 Jan; 16(1):59-65. PubMed ID: 29295882
[No Abstract] [Full Text] [Related]
24. Prior chemoradiotherapy adversely impacts outcomes of recurrent and second primary head and neck cancer treated with concurrent chemotherapy and reirradiation.
Choe KS; Haraf DJ; Solanki A; Cohen EE; Seiwert TY; Stenson KM; Blair EA; Portugal L; Villaflor VM; Witt ME; Vokes EE; Salama JK
Cancer; 2011 Oct; 117(20):4671-8. PubMed ID: 21671479
[TBL] [Abstract][Full Text] [Related]
25. Survival of patients with resectable pancreatic cancer who received neoadjuvant therapy.
Christians KK; Heimler JW; George B; Ritch PS; Erickson BA; Johnston F; Tolat PP; Foley WD; Evans DB; Tsai S
Surgery; 2016 Mar; 159(3):893-900. PubMed ID: 26602840
[TBL] [Abstract][Full Text] [Related]
26. Regional hyperthermia combined with chemoradiotherapy in primary or recurrent locally advanced pancreatic cancer : an open-label comparative cohort trial.
Maluta S; Schaffer M; Pioli F; Dall'oglio S; Pasetto S; Schaffer PM; Weber B; Giri MG
Strahlenther Onkol; 2011 Oct; 187(10):619-25. PubMed ID: 21932025
[TBL] [Abstract][Full Text] [Related]
27. Chemotherapy and intensity-modulated radiation therapy for locally advanced pancreatic cancer achieves a high rate of R0 resection.
Huguet F; Hajj C; Winston CB; Shi W; Zhang Z; Wu AJ; O'Reilly EM; Reidy DL; Allen P; Goodman KA
Acta Oncol; 2017 Mar; 56(3):384-390. PubMed ID: 27796165
[TBL] [Abstract][Full Text] [Related]
28. A phase II study of adjuvant S-1/cisplatin chemotherapy followed by S-1-based chemoradiotherapy for D2-resected gastric cancer.
Shim HJ; Kim KR; Hwang JE; Bae WK; Ryu SY; Park YK; Nam TK; Chung IJ; Cho SH
Cancer Chemother Pharmacol; 2016 Mar; 77(3):605-12. PubMed ID: 26846507
[TBL] [Abstract][Full Text] [Related]
29. Chemoradiation for resected pancreatic adenocarcinoma with or without intraoperative radiation therapy boost: Long-term outcomes.
Calvo FA; Sole CV; Atahualpa F; Lozano MA; Gomez-Espi M; Calin A; García-Alfonso P; Gonzalez-Bayon L; Herranz R; García-Sabrido JL
Pancreatology; 2013; 13(6):576-82. PubMed ID: 24280572
[TBL] [Abstract][Full Text] [Related]
30. Surgery and multimodal treatments in pancreatic cancer--a review on the basis of future multimodal treatment concepts.
Link KH; Leder G; Formentini A; Fortnagel G; Kornmann M; Schatz M; Beger HG
Gan To Kagaku Ryoho; 1999 Jan; 26(1):10-40. PubMed ID: 9987495
[TBL] [Abstract][Full Text] [Related]
31. Capecitabine as a Radiosensitizer in Adjuvant Chemoradiotherapy for Pancreatic Cancer: A Retrospective Study.
Abrams MJ; Huber KE; Knisely JP; Chang BW; Russo SM; Saif MW
Anticancer Res; 2015 Dec; 35(12):6901-7. PubMed ID: 26637914
[TBL] [Abstract][Full Text] [Related]
32. Review of adjuvant radiochemotherapy for resected pancreatic cancer and results from Mayo Clinic for the 5th JUCTS symposium.
Miller RC; Iott MJ; Corsini MM
Int J Radiat Oncol Biol Phys; 2009 Oct; 75(2):364-8. PubMed ID: 19735864
[TBL] [Abstract][Full Text] [Related]
33. Dose-Response Relationship between Radiation Dose and Loco-regional Control in Patients with Stage II-III Esophageal Cancer Treated with Definitive Chemoradiotherapy.
Kim HJ; Suh YG; Lee YC; Lee SK; Shin SK; Cho BC; Lee CG
Cancer Res Treat; 2017 Jul; 49(3):669-677. PubMed ID: 27737537
[TBL] [Abstract][Full Text] [Related]
34. Impact of chemoradiotherapy after disease control with chemotherapy in locally advanced pancreatic adenocarcinoma in GERCOR phase II and III studies.
Huguet F; André T; Hammel P; Artru P; Balosso J; Selle F; Deniaud-Alexandre E; Ruszniewski P; Touboul E; Labianca R; de Gramont A; Louvet C
J Clin Oncol; 2007 Jan; 25(3):326-31. PubMed ID: 17235048
[TBL] [Abstract][Full Text] [Related]
35. Adjuvant radiotherapy and chemotherapy for pancreatic carcinoma: the Mayo Clinic experience (1975-2005).
Corsini MM; Miller RC; Haddock MG; Donohue JH; Farnell MB; Nagorney DM; Jatoi A; McWilliams RR; Kim GP; Bhatia S; Iott MJ; Gunderson LL
J Clin Oncol; 2008 Jul; 26(21):3511-6. PubMed ID: 18640932
[TBL] [Abstract][Full Text] [Related]
36. A randomized trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancer.
Neoptolemos JP; Stocken DD; Friess H; Bassi C; Dunn JA; Hickey H; Beger H; Fernandez-Cruz L; Dervenis C; Lacaine F; Falconi M; Pederzoli P; Pap A; Spooner D; Kerr DJ; Büchler MW;
N Engl J Med; 2004 Mar; 350(12):1200-10. PubMed ID: 15028824
[TBL] [Abstract][Full Text] [Related]
37. Chemoradiotherapy before and after surgery for locally advanced esophageal cancer: a SEER-Medicare analysis.
Hong JC; Murphy JD; Wang SJ; Koong AC; Chang DT
Ann Surg Oncol; 2013 Nov; 20(12):3999-4007. PubMed ID: 23800897
[TBL] [Abstract][Full Text] [Related]
38. Induction chemotherapy with docetaxel/cisplatin/5-fluorouracil followed by randomization to two cisplatin-based concomitant chemoradiotherapy schedules in patients with locally advanced head and neck cancer (CONDOR study) (Dutch Head and Neck Society 08-01): A randomized phase II study.
Driessen CM; de Boer JP; Gelderblom H; Rasch CR; de Jong MA; Verbist BM; Melchers WJ; Tesselaar ME; van der Graaf WT; Kaanders JH; van Herpen CM
Eur J Cancer; 2016 Jan; 52():77-84. PubMed ID: 26655558
[TBL] [Abstract][Full Text] [Related]
39. Adjuvant radiotherapy and lymph node dissection in pancreatic cancer treated with surgery and chemotherapy.
Mellon EA; Springett GM; Hoffe SE; Hodul P; Malafa MP; Meredith KL; Fulp WJ; Zhao X; Shridhar R
Cancer; 2014 Apr; 120(8):1171-7. PubMed ID: 24390779
[TBL] [Abstract][Full Text] [Related]
40. Does preoperative therapy optimize outcomes in patients with resectable pancreatic cancer?
Papalezova KT; Tyler DS; Blazer DG; Clary BM; Czito BG; Hurwitz HI; Uronis HE; Pappas TN; Willett CG; White RR
J Surg Oncol; 2012 Jul; 106(1):111-8. PubMed ID: 22311829
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]